PHARMACOLOGICAL PROFILE OF CGS-24128, A POTENT, LONG-ACTING INHIBITOR OF NEUTRAL ENDOPEPTIDASE-24.11

被引:7
作者
TRAPANI, AJ
BELL, ME
COTE, DT
DELOMBAERT, S
ERION, MD
GERLOCK, TE
GHAI, RD
HOPKINS, MF
PEPPARD, JV
WEBB, RL
LAPPE, RW
WORCEL, M
机构
关键词
ATRIAL NATRIURETIC PEPTIDE; NEUTRAL ENDOPEPTIDASE; THIORPHAN; PHARMACOKINETICS; DIURESIS; NATRIURESIS; ARTERIAL PRESSURE;
D O I
10.1097/00005344-199423030-00001
中图分类号
R5 [内科学];
学科分类号
1002 [临床医学]; 100201 [内科学];
摘要
We compared the pharmacologic profiles of thiorphan, a neutral endopeptidase (NEP) inhibitor which is cleared rapidly from the circulation, and CGS 24128, an inhibitor with a much longer half-life (t1/2). Thiorphan and CGS 24128 inhibited NEP in vitro with IC50 values of 5.0 +/- 0.2 and 4.3 +/- 0.2 nM, respectively. After administration at 10 mg/kg intravenously (i.v.), the concentrations of CGS 24128 in the plasma were >500 nM for 4 h but plasma thiorphan was detectable for only 60 min. Thiorphan 3 mg/kg administered intraarterially (i.a.) increased plasma atrial natriuretic peptide immunoreactivity (ANPir) levels by 58 +/- 12% in rats administered exogenous ANP(99-126). This response lasted <60 min, whereas the same dose of CGS 24128 produced an average increase of 191 +/- 19% in ANPir concentrations that persisted for 4 h. ANP-induced (1 mu g/kg i.v.) natriuresis was significantly potentiated in anesthetized rats pretreated (60 min) with a bolus of CGS 24128 10 mg/kg i.v. The change in urinary sodium excretion (UNaV) produced by ANP was 28.8 +/- 4.0 and 15.8 +/- 1.8 mu Eq/kg/min in CGS 24128- and vehicle-treated rats, respectively. ANP-induced natriuresis was also greater during continuous infusion of thiorphan (5 mg/kg bolus + 0.1 mg/kg/min i.v.; Delta UNaV = 29.2 +/- 5.8 and 13.8 +/- 3.2 mu Eq/kg/min in drug- and vehicle-treated rats, respectively) but not when thiorphan was administered as a bolus (10 mg/kg i.v.) 60 min before the ANP challenge. Similarly, continuous infusion of thiorphan (0.5 mg/kg/min i.v.) or CGS 24128, given as a bolus (10 mg/kg i.v.), decreased mean arterial pressure (MAP) by 26 +/- 7 and 31 +/- 6 mm Hg, respectively, in DOCA-salt hypertensive rats. This antihypertensive effect was not observed after i.v. bolus injection of thiorphan 30 mg/kg. These data indicate that potent NEP inhibitors can potentiate the biologic actions of endogenous and exogenous ANP, but the efficacy of some compounds is significantly limited by their rate of clearance in vivo.
引用
收藏
页码:358 / 364
页数:7
相关论文
共 34 条
[1]
VASOPRESSIN-CENTRAL NERVOUS-SYSTEM INTERACTIONS IN THE DEVELOPMENT OF DOCA HYPERTENSION [J].
BERECEK, KH ;
BARRON, KW ;
WEBB, RL ;
BRODY, MJ .
HYPERTENSION, 1982, 4 (03) :131-137
[2]
BEVAN EG, 1992, J HYPERTENS, V10, P607
[3]
CARDIORENAL ACTIONS OF NEUTRAL ENDOPEPTIDASE INHIBITION IN EXPERIMENTAL CONGESTIVE HEART-FAILURE [J].
CAVERO, PG ;
MARGULIES, KB ;
WINAVER, J ;
SEYMOUR, AA ;
DELANEY, NG ;
BURNETT, JC .
CIRCULATION, 1990, 82 (01) :196-201
[4]
CHIPKIN R E, 1986, Drugs of the Future, V11, P593
[5]
UK-69,578, A NOVEL INHIBITOR OF EC-342411 WHICH INCREASES ENDOGENOUS ANF LEVELS AND IS NATRIURETIC AND DIURETIC [J].
DANILEWICZ, JC ;
BARCLAY, PL ;
BARNISH, IT ;
BROWN, D ;
CAMPBELL, SF ;
JAMES, K ;
SAMUELS, GMR ;
TERRETT, NK ;
WYTHES, MJ .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1989, 164 (01) :58-65
[6]
NEUTRAL ENDOPEPTIDASE 24.11 (ENKEPHALINASE) AND RELATED REGULATORS OF PEPTIDE-HORMONES [J].
ERDOS, EG ;
SKIDGEL, RA .
FASEB JOURNAL, 1989, 3 (02) :145-151
[7]
ROLE OF ENDOPEPTIDASE-24.11 IN THE INACTIVATION OF ATRIAL NATRIURETIC PEPTIDE [J].
KENNY, AJ ;
STEPHENSON, SL .
FEBS LETTERS, 1988, 232 (01) :1-8
[8]
KOEPKE JP, 1989, J PHARMACOL EXP THER, V249, P172
[9]
PHYSIOLOGICAL-ROLE OF SILENT RECEPTORS OF ATRIAL-NATRIURETIC-FACTOR [J].
MAACK, T ;
SUZUKI, M ;
ALMEIDA, FA ;
NUSSENZVEIG, D ;
SCARBOROUGH, RM ;
MCENROE, GA ;
LEWICKI, JA .
SCIENCE, 1987, 238 (4827) :675-678
[10]
A SIMPLE AND RAPID METHOD FOR THE PREPARATION OF PLASMA-MEMBRANES [J].
MAEDA, T ;
BALAKRISHNAN, K ;
MEHDI, SQ .
BIOCHIMICA ET BIOPHYSICA ACTA, 1983, 731 (01) :115-120